|
Results of bacterial gene point mutation assay. Positive control data. |
||||||||||
| Experiment 2 |
||||||||||
| TA100 |
TA1535 |
TA102 |
TA98 |
TA1537 |
||||||
|
|
||||||||||
| (-S9) |
(+S9) |
(-S9) |
(+S9) |
(-S9) |
(+S9) |
(-S9) |
(+S9) |
(-S9) |
(+S9) |
|
|
|
||||||||||
| Compound |
ENNG |
2AA |
ENNG |
2AA |
MMC |
DAN |
4NQO |
BP |
9AA |
2AA |
| Dose Level |
3 μg |
1 μg |
5 μg |
2 μg |
0.5 μg |
10 μg |
0.2 μg |
5 μg |
80 μg |
2 μg |
| Mean ± S.D. |
687 ± 88 |
1055 ± 181 |
706 ± 38 |
304 ± 49 |
1370 ± 86 |
832 ± 53 |
247 ± 8 |
353 ± 84 |
1909 ± 192 |
207 ± 44 |
|
S.D. Standard deviation ENNG N-Ethyl-N'-nitro-N-nitrosoguanidine MMC Mitomycin C 4NQO 4-Nitroquinoline-1-oxide 9AA 9-Aminoacridine 2AA 2-Aminoanthracene DAN 1,8-dihydroxyanthraquinone BP Benzo-a-Pyrene | ||||||||||
Park et al. Particle and Fibre Toxicology 2007 4:12 doi:10.1186/1743-8977-4-12 |
||||||||||